美敦力康辉亮相第八届进博会，AiBLE 数智生态加速进化拓维

Core Viewpoint - The eighth China International Import Expo (CIIE) showcases Medtronic's commitment to local innovation and global collaboration in high-end medical equipment, highlighting the launch of innovative technologies in minimally invasive surgery [1][3][10]. Group 1: Innovation and Technology - Medtronic's AiBLE digital innovation ecosystem, first introduced at the sixth CIIE in 2023, aims to transition orthopedic and neurosurgery from "single-point innovation" to "system collaboration" [4]. - The company presented several star products from the AiBLE ecosystem, including the Mazor XC spinal surgery robot and the NIM-Eclipse intraoperative neuro-monitoring system, which have successfully transitioned from exhibition to clinical application [4][15]. - Medtronic, in collaboration with Jin Hai Medical and Jia Liang Medical, launched two innovative technologies: "navigation-assisted spinal endoscopic minimally invasive technology" and "robot-guided laser ablation minimally invasive technology" [1][10]. Group 2: Local Collaboration and Market Expansion - Medtronic emphasizes deepening local innovation partnerships to explore new technologies and trends in orthopedic and neurosurgery, responding to the growing demand for minimally invasive procedures [10][11]. - The company has established a comprehensive global capability covering research, manufacturing, registration, and sales, with products now available in 65 countries and regions [12]. - The NIM-Eclipse system has recently entered the Japanese market, marking a significant milestone in Medtronic's global expansion efforts [12][15]. Group 3: Future Outlook - Medtronic aims to continue leveraging the AiBLE digital innovation ecosystem to foster open collaboration and sustainable development in medical innovation, ensuring that Chinese innovations benefit global patients [15].